Researchers in Hong Kong have found that patients experiencing milder illness caused by the novel coronavirus recover more quickly if they are treated with a three-drug antiviral cocktail soon after symptoms appear.
Authors of the study, published in The Lancet on Friday, described the findings as “early, but important.”
They called for larger-scale research on critically ill patients to ascertain if the drug combo could be a viable treatment for them, too.
“Our trial demonstrates that early treatment of mild to moderate COVID-19 with a triple combination of antiviral drugs may rapidly suppress the amount of virus in a patient’s body,” said University of Hong Kong professor of microbiology Yuen Kwok-yung (袁國勇), who led the research.
The treatment, which appeared safe in patients, was shown to “relieve symptoms, and reduce the risk to healthcare workers by reducing the duration and quantity of viral shedding (when the virus is detectable and potentially transmissible),” Yuen wrote.
Scientists are racing to identify medicines to use against COVID-19, but there is currently no treatment, cure or vaccine.
The study tracked the virus in 127 adults admitted to six hospitals in Hong Kong after they tested positive.
Of those participating, 86 were given a two-week course of three medicines: interferon beta-1b, a drug used to treat multiple sclerosis; a combination of lopinavir and ritonavir used to fight HIV; and ribavirin, used to treat hepatitis.
A randomly assigned control group of 41 people was just given the lopinavir-ritonavir combination.
Treatment began on average five days after symptoms started and all patients otherwise received standard care, including oxygen therapy.
Researchers then measured how long it took for a swab test for the virus to turn out negative. They found that those taking all three medicines were able to clear the coronavirus in seven days on average (between five and 11 days) — “significantly” shorter than the 12-day average for the control group.
Those on the three-drug regimen also saw a complete alleviation of their symptoms in an average of four days, compared with eight for the control group.
“Future clinical study of a double antiviral therapy with interferon beta-1b as a backbone is warranted,” the study said.
GEARING UP: An invasion would be difficult and would strain China’s forces, but it has conducted large-scale training supporting an invasion scenario, the report said China increased its military pressure on Taiwan last year and took other steps in preparation for a potential invasion, an annual report published by the US Department of Defense on Wednesday showed. “Throughout 2023, Beijing continued to erode longstanding norms in and around Taiwan by employing a range of pressure tactics against Taiwan,” the report said, which is titled “Military and Security Developments Involving the People’s Republic of China (PRC) 2024.” The Chinese People’s Liberation Army (PLA) “is preparing for a contingency to unify Taiwan with the PRC by force, if perceived as necessary by Beijing, while simultaneously deterring, delaying or denying
PEACEFUL RESOLUTION: A statement issued following a meeting between Australia and Britain reiterated support for Taiwan and opposition to change in the Taiwan Strait Canada should support the peaceful resolution of Taiwan’s destiny according to the will of Taiwanese, Canadian lawmakers said in a resolution marking the second anniversary of that nation’s Indo-Pacific strategy on Monday. The Canadian House of Commons committee on Canada-Chinese relations made the comment as part of 34 recommendations for the new edition of the strategy, adding that Ottawa should back Taiwan’s meaningful participation in international organizations. Canada’s Indo-Pacific Strategy, first published in October 2022, emphasized that the region’s security, trade, human rights, democracy and environmental protection would play a crucial role in shaping Canada’s future. The strategy called for Canada to deepen
TECH CONFERENCE: Input from industry and academic experts can contribute to future policymaking across government agencies, President William Lai said Multifunctional service robots could be the next new area in which Taiwan could play a significant role, given its strengths in chip manufacturing and software design, Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) chairman and chief executive C.C. Wei (魏哲家) said yesterday. “In the past two months, our customers shared a lot of their future plans with me. Artificial intelligence [AI] and AI applications were the most talked about subjects in our conversation,” Wei said in a speech at the National Science and Technology Conference in Taipei. TSMC, the world’s biggest contract chipmaker, counts Nvidia Corp, Advanced Micro Devices Inc, Apple Inc and
LEAP FORWARD: The new tanks are ‘decades more advanced than’ the army’s current fleet and would enable it to compete with China’s tanks, a source said A shipment of 38 US-made M1A2T Abrams tanks — part of a military procurement package from the US — arrived at the Port of Taipei early yesterday. The vehicles are the first batch of 108 tanks and other items that then-US president Donald Trump announced for Taiwan in 2019. The Ministry of National Defense at the time allocated NT$40.5 billion (US$1.25 billion) for the purchase. To accommodate the arrival of the tanks, the port suspended the use of all terminals and storage area machinery from 6pm last night until 7am this morning. The tanks are expected to be deployed at the army’s training
RSS